{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T16:10:54Z","timestamp":1778256654056,"version":"3.51.4"},"reference-count":28,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec>\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Optimal clinical decision support system (CDSS) implementation for chronic kidney disease (CKD) management in Chinese primary care remains undefined despite the high disease burden.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To examine whether a CDSS for CKD could improve physician behavior and patient outcomes in primary care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This cluster randomized clinical trial is being conducted in Chinese primary care centers. The trial spans a 3-year period (January 1, 2023, to December 31, 2026) and is divided into 2 phases; this phase 1 analysis includes data from the initial 6-month follow-up (June 10 to December 10, 2023). Centers were stratified by size and randomized 1:1 to intervention or control. Participants are adults (aged \u226518 years) with CKD who had 2 visits or more during the 1-year screening period, all enrolled before randomization.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions<\/jats:title>\n                    <jats:p>Both groups received government-supported, nephrologist-delivered training on CKD management. The intervention group was additionally equipped with a CDSS embedded into the electronic health record.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>The primary outcome was a 36-month composite of kidney-related and cardiovascular hospitalizations (phase 2). This phase 1 analysis evaluated 6-month process measures (ie, CKD diagnosis and renin-angiotensin-aldosterone system inhibitor or sodium-dependent glucose transporter 2 inhibitor use) and clinical outcomes (ie, blood pressure, glycated hemoglobin, and low-density lipoprotein cholesterol control).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 3390 patients (mean [SD] age, 72.0 [10.2] years; 1881 [55.5%] female) from 30 primary care centers were included (1912 in the intervention group and 1478 in the control group). Follow-up at 6 months was completed by 3055 patients (90.1%; 1743 [91.2%] in the intervention group and 1312 [88.8%] in the control group). CKD diagnosis rates increased by 21.4 (95% CI, 18.6-24.3) percentage points in the intervention group and by 27.9 (95% CI, 24.4-31.3) percentage points in the control group, with a nonsignificant between-group difference (adjusted odds ratio [AOR], 0.91; 95% CI, 0.72-1.14). Renin-angiotensin-aldosterone system inhibitor use (AOR, 0.96; 95% CI, 0.78-1.19), sodium-dependent glucose transporter 2 inhibitor use (AOR, 1.02; 95% CI, 0.78-1.32), and low-density lipoprotein cholesterol control (AOR, 1.10; 95% CI, 0.83-1.46) showed parallel improvements with no between-group differences. Blood pressure (AOR, 0.88; 95% CI, 0.71-1.09) and glycated hemoglobin (AOR, 1.22; 95% CI, 0.74-2.01) control showed no improvement.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In this cluster randomized trial of a CDSS for CKD in primary care, both the intervention and control groups demonstrated comparable improvements in 6-month outcomes, with no independent effect of the CDSS detected.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial Registration<\/jats:title>\n                    <jats:p>\n                      Chinese Clinical Trial Registry Identifier:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.chictr.org.cn\/showprojEN.html?proj=190626\">ChiCTR2300070555<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.11112","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T15:30:22Z","timestamp":1778254222000},"page":"e2611112","source":"Crossref","is-referenced-by-count":0,"title":["Clinical Decision Support for Chronic Kidney Disease in Primary Care"],"prefix":"10.1001","volume":"9","author":[{"given":"Xizi","family":"Zheng","sequence":"first","affiliation":[{"name":"Renal Division, Peking University First Hospital, Institute of Nephrology, Peking University, Key Laboratory of Renal Disease, Ministry of Health of China, Beijing, China"},{"name":"Beijing Key Laboratory of Precision Medicine and New-drug\/Equipment Development for Severe Kidney Disease, Beijing, China"},{"name":"Key Laboratory of CKD Prevention and Treatment, Ministry of Education of China, Beijing, China"},{"name":"Research Units of Diagnosis and Treatment of Immune-Mediated Kidney Diseases, Chinese Academy of Medical Sciences, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miao","family":"Hui","sequence":"additional","affiliation":[{"name":"Renal Division, Peking University First Hospital, Institute of Nephrology, Peking University, Key Laboratory of Renal Disease, Ministry of Health of China, Beijing, China"},{"name":"Key Laboratory of CKD Prevention and Treatment, Ministry of Education of China, Beijing, China"},{"name":"Research Units of Diagnosis and Treatment of Immune-Mediated Kidney Diseases, Chinese Academy of Medical Sciences, Beijing, China"},{"name":"Division of Sleep Medicine, Peking University People\u2019s Hospital, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyu","family":"Yang","sequence":"additional","affiliation":[{"name":"Renal Division, Peking University First Hospital, Institute of Nephrology, Peking University, Key Laboratory of Renal Disease, Ministry of Health of China, Beijing, China"},{"name":"Beijing Key Laboratory of Precision Medicine and New-drug\/Equipment Development for Severe Kidney Disease, Beijing, China"},{"name":"Key Laboratory of CKD Prevention and Treatment, Ministry of Education of China, Beijing, China"},{"name":"Research Units of Diagnosis and Treatment of Immune-Mediated Kidney Diseases, Chinese Academy of Medical Sciences, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhao","family":"Yang","sequence":"additional","affiliation":[{"name":"Office of Discipline and Talent, Peking University First Hospital, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linger","family":"Tang","sequence":"additional","affiliation":[{"name":"Renal Division, Peking University First Hospital, Institute of Nephrology, Peking University, Key Laboratory of Renal Disease, Ministry of Health of China, Beijing, China"},{"name":"Beijing Key Laboratory of Precision Medicine and New-drug\/Equipment Development for Severe Kidney Disease, Beijing, China"},{"name":"Key Laboratory of CKD Prevention and Treatment, Ministry of Education of China, Beijing, China"},{"name":"Research Units of Diagnosis and Treatment of Immune-Mediated Kidney Diseases, Chinese Academy of Medical Sciences, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youlu","family":"Zhao","sequence":"additional","affiliation":[{"name":"Renal Division, Peking University First Hospital, Institute of Nephrology, Peking University, Key Laboratory of Renal Disease, Ministry of Health of China, Beijing, China"},{"name":"Beijing Key Laboratory of Precision Medicine and New-drug\/Equipment Development for Severe Kidney Disease, Beijing, China"},{"name":"Key Laboratory of CKD Prevention and Treatment, Ministry of Education of China, Beijing, China"},{"name":"Research Units of Diagnosis and Treatment of Immune-Mediated Kidney Diseases, Chinese Academy of Medical Sciences, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingyi","family":"Xu","sequence":"additional","affiliation":[{"name":"Renal Division, Peking University First Hospital, Institute of Nephrology, Peking University, Key Laboratory of Renal Disease, Ministry of Health of China, Beijing, China"},{"name":"Beijing Key Laboratory of Precision Medicine and New-drug\/Equipment Development for Severe Kidney Disease, Beijing, China"},{"name":"Key Laboratory of CKD Prevention and Treatment, Ministry of Education of China, Beijing, China"},{"name":"Research Units of Diagnosis and Treatment of Immune-Mediated Kidney Diseases, Chinese Academy of Medical Sciences, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingqing","family":"Zhou","sequence":"additional","affiliation":[{"name":"Renal Division, Peking University First Hospital, Institute of Nephrology, Peking University, Key Laboratory of Renal Disease, Ministry of Health of China, Beijing, China"},{"name":"Beijing Key Laboratory of Precision Medicine and New-drug\/Equipment Development for Severe Kidney Disease, Beijing, China"},{"name":"Key Laboratory of CKD Prevention and Treatment, Ministry of Education of China, Beijing, China"},{"name":"Research Units of Diagnosis and Treatment of Immune-Mediated Kidney Diseases, Chinese Academy of Medical Sciences, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingwei","family":"Wang","sequence":"additional","affiliation":[{"name":"Renal Division, Peking University First Hospital, Institute of Nephrology, Peking University, Key Laboratory of Renal Disease, Ministry of Health of China, Beijing, China"},{"name":"Beijing Key Laboratory of Precision Medicine and New-drug\/Equipment Development for Severe Kidney Disease, Beijing, China"},{"name":"Key Laboratory of CKD Prevention and Treatment, Ministry of Education of China, Beijing, China"},{"name":"Research Units of Diagnosis and Treatment of Immune-Mediated Kidney Diseases, Chinese Academy of Medical Sciences, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengrui","family":"Li","sequence":"additional","affiliation":[{"name":"Renal Division, Peking University First Hospital, Institute of Nephrology, Peking University, Key Laboratory of Renal Disease, Ministry of Health of China, Beijing, China"},{"name":"Beijing Key Laboratory of Precision Medicine and New-drug\/Equipment Development for Severe Kidney Disease, Beijing, China"},{"name":"Key Laboratory of CKD Prevention and Treatment, Ministry of Education of China, Beijing, China"},{"name":"Research Units of Diagnosis and Treatment of Immune-Mediated Kidney Diseases, Chinese Academy of Medical Sciences, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuhong","family":"Zhu","sequence":"additional","affiliation":[{"name":"Xicheng District Center for Smart Health and Digital Intelligence, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengjuan","family":"Gao","sequence":"additional","affiliation":[{"name":"Beijing Xicheng District Desheng Community Health Service Center, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[{"name":"Beijing Xicheng District Desheng Community Health Service Center, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jicheng","family":"Lv","sequence":"additional","affiliation":[{"name":"Renal Division, Peking University First Hospital, Institute of Nephrology, Peking University, Key Laboratory of Renal Disease, Ministry of Health of China, Beijing, China"},{"name":"Beijing Key Laboratory of Precision Medicine and New-drug\/Equipment Development for Severe Kidney Disease, Beijing, China"},{"name":"Key Laboratory of CKD Prevention and Treatment, Ministry of Education of China, Beijing, China"},{"name":"Research Units of Diagnosis and Treatment of Immune-Mediated Kidney Diseases, Chinese Academy of Medical Sciences, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[{"name":"Renal Division, Peking University First Hospital, Institute of Nephrology, Peking University, Key Laboratory of Renal Disease, Ministry of Health of China, Beijing, China"},{"name":"Beijing Key Laboratory of Precision Medicine and New-drug\/Equipment Development for Severe Kidney Disease, Beijing, China"},{"name":"Key Laboratory of CKD Prevention and Treatment, Ministry of Education of China, Beijing, China"},{"name":"Research Units of Diagnosis and Treatment of Immune-Mediated Kidney Diseases, Chinese Academy of Medical Sciences, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","published-online":{"date-parts":[[2026,5,8]]},"reference":[{"issue":"7","key":"zoi260339r1","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41581-024-00820-6","article-title":"Chronic kidney disease and the global public health agenda: an international consensus.","volume":"20","author":"Francis","year":"2024","journal-title":"Nat Rev Nephrol"},{"issue":"4","key":"zoi260339r2","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1001\/jamainternmed.2022.6817","article-title":"Prevalence of chronic kidney disease in China: results from the Sixth China Chronic Disease and Risk Factor Surveillance.","volume":"183","author":"Wang","year":"2023","journal-title":"JAMA Intern Med"},{"issue":"10","key":"zoi260339r3","doi-asserted-by":"publisher","first-page":"3757","DOI":"10.1007\/s12325-024-02957-z","article-title":"Early identification and management of chronic kidney disease: a narrative review of the crucial role of primary care practitioners.","volume":"41","author":"Kushner","year":"2024","journal-title":"Adv Ther"},{"issue":"4","key":"zoi260339r4","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1053\/j.ajkd.2010.11.013","article-title":"Recognition and management of CKD in primary care.","volume":"57","author":"Litvin","year":"2011","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"zoi260339r5","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1053\/j.ajkd.2010.08.029","article-title":"Impact of estimated GFR reporting on patients, clinicians, and health-care systems: a systematic review.","volume":"57","author":"Kagoma","year":"2011","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"zoi260339r6","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1001\/jama.2010.303","article-title":"Nephrology visits and health care resource use before and after reporting estimated glomerular filtration rate.","volume":"303","author":"Hemmelgarn","year":"2010","journal-title":"JAMA"},{"issue":"4","key":"zoi260339r7","doi-asserted-by":"publisher","first-page":"565","DOI":"10.2215\/CJN.12391211","article-title":"A cluster randomized trial of an enhanced eGFR prompt in chronic kidney disease.","volume":"7","author":"Manns","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"zoi260339r8","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.3377","article-title":"Effect of 2 clinical decision support strategies on chronic kidney disease outcomes in primary care: a cluster randomized trial.","volume":"1","author":"Carroll","year":"2018","journal-title":"JAMA Netw Open"},{"issue":"3","key":"zoi260339r9","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.kint.2024.04.020","article-title":"A stepped wedge cluster randomized trial of graphical surveillance of kidney function data to reduce late presentation for kidney replacement therapy.","volume":"106","author":"Gallagher","year":"2024","journal-title":"Kidney Int"},{"issue":"5","key":"zoi260339r10","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1053\/j.ajkd.2020.05.013","article-title":"Electronic decision support for management of CKD in primary care: a pragmatic randomized trial.","volume":"76","author":"Peralta","year":"2020","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"zoi260339r11","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1001\/jamainternmed.2023.8315","article-title":"Clinical decision support for hypertension management in chronic kidney disease: a randomized clinical trial.","volume":"184","author":"Samal","year":"2024","journal-title":"JAMA Intern Med"},{"issue":"13","key":"zoi260339r12","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1001\/jama.2023.17002","article-title":"Estimated glomerular filtration rate, albuminuria, and adverse outcomes: an individual-participant data meta-analysis.","volume":"330","author":"Grams","year":"2023","journal-title":"JAMA"},{"issue":"3","key":"zoi260339r13","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1093\/ije\/dyz237","article-title":"A tutorial on sample size calculation for multiple-period cluster randomized parallel, cross-over and stepped-wedge trials using the Shiny CRT Calculator.","volume":"49","author":"Hemming","year":"2020","journal-title":"Int J Epidemiol"},{"issue":"10492","key":"zoi260339r14","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1016\/S0140-6736(25)00548-3","article-title":"Reducing the burden of chronic kidney disease in the world.","volume":"405","author":"Lou-Meda","year":"2025","journal-title":"Lancet"},{"issue":"3","key":"zoi260339r15","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/ki.2013.96","article-title":"Audit-based education lowers systolic blood pressure in chronic kidney disease: the Quality Improvement in CKD (QICKD) trial results.","volume":"84","author":"Lusignan","year":"2013","journal-title":"Kidney Int"},{"key":"zoi260339r16","doi-asserted-by":"publisher","first-page":"m3216","DOI":"10.1136\/bmj.m3216","article-title":"Computerised clinical decision support systems and absolute improvements in care: meta-analysis of controlled clinical trials.","volume":"370","author":"Kwan","year":"2020","journal-title":"BMJ"},{"issue":"11","key":"zoi260339r17","doi-asserted-by":"publisher","first-page":"3646","DOI":"10.1093\/ndt\/gfr164","article-title":"Late presentation of patients with end-stage renal disease for renal replacement therapy\u2013is it always avoidable?","volume":"26","author":"Udayaraj","year":"2011","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"zoi260339r18","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1093\/ckj\/sfac218","article-title":"Temporal trends in prevalence and mortality for chronic kidney disease in China from 1990 to 2019: an analysis of the Global Burden of Disease Study 2019.","volume":"16","author":"Li","year":"2022","journal-title":"Clin Kidney J"},{"issue":"1","key":"zoi260339r19","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.kisu.2024.02.001","article-title":"Capacity for the management of kidney failure in the International Society of Nephrology North and East Asia region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA).","volume":"13","author":"Wing-Shing Fung","year":"2024","journal-title":"Kidney Int Suppl (2011)"},{"issue":"2","key":"zoi260339r20","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1053\/j.ajkd.2018.01.058","article-title":"Impact of a primary care CKD registry in a US public safety-net health care delivery system: a pragmatic randomized trial.","volume":"72","author":"Tuot","year":"2018","journal-title":"Am J Kidney Dis"},{"issue":"10239","key":"zoi260339r21","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1016\/S0140-6736(20)30122-7","article-title":"Quality of primary health care in China: challenges and recommendations.","volume":"395","author":"Li","year":"2020","journal-title":"Lancet"},{"issue":"11","key":"zoi260339r22","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1093\/ckj\/sfab089","article-title":"Influence of doctors\u2019 perception on the diagnostic status of chronic kidney disease: results from 976?409 individuals with electronic health records in China.","volume":"14","author":"Wang","year":"2021","journal-title":"Clin Kidney J"},{"issue":"11","key":"zoi260339r23","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.2215\/CJN.04510416","article-title":"Prevalence of barriers and facilitators to enhancing conservative kidney management for older adults in the primary care setting.","volume":"11","author":"Tam-Tham","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11","key":"zoi260339r24","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1093\/ndt\/gfv408","article-title":"Primary care physicians\u2019 perceived barriers, facilitators and strategies to enhance conservative care for older adults with chronic kidney disease: a qualitative descriptive study.","volume":"31","author":"Tam-Tham","year":"2016","journal-title":"Nephrol Dial Transplant"},{"issue":"8","key":"zoi260339r25","first-page":"902","article-title":"Guidelines for the early evaluation and management of chronic kidney disease in China","volume":"62","year":"2023","journal-title":"Zhonghua Nei Ke Za Zhi"},{"issue":"7","key":"zoi260339r26","doi-asserted-by":"publisher","DOI":"10.1016\/j.xkme.2022.100493","article-title":"Impact of kidney failure risk prediction clinical decision support on monitoring and referral in primary care management of CKD: a randomized pragmatic clinical trial.","volume":"4","author":"Samal","year":"2022","journal-title":"Kidney Med"},{"issue":"3","key":"zoi260339r27","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1370\/afm.310","article-title":"Is there time for management of patients with chronic diseases in primary care?","volume":"3","author":"\u00d8stbye","year":"2005","journal-title":"Ann Fam Med"},{"issue":"4","key":"zoi260339r28","first-page":"e107","article-title":"Physician and patient tools to improve chronic kidney disease care.","volume":"24","author":"Sequist","year":"2018","journal-title":"Am J Manag Care"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2848778\/zheng_2026_oi_260339_1777989004.57102.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T15:30:22Z","timestamp":1778254222000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2848778"}},"subtitle":["A Cluster Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.11112","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]}}}